Body Composition & Fatty Liver Disease

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05979779` - Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis	Phase 2
Recruiting	`NCT06051669` - Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US
Not yet recruiting	`NCT05984745` - Effect of CoQ10 on the Outcome of MAFLD Patients	Phase 2
Completed	`NCT02565446` - Transforming Non-Invasive Liver Disease Detection by MRE: The Hepatogram	N/A
Not yet recruiting	`NCT01694342` - Telomere Parameters in Patients With Nonalcoholic Fatty Liver	N/A
Completed	`NCT01464801` - Resveratrol in Patients With Non-alcoholic Fatty Liver Disease	N/A
Completed	`NCT01992809` - Omega 3 Supplementation in Fatty Liver	Phase 3
Completed	`NCT00244569` - Development of a Breath Test for Monitoring Patients With Liver Disease	Phase 3
Completed	`NCT00063635` - Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)	Phase 3
Recruiting	`NCT03972319` - Omega-3 Supplementation for LIver VolumE Reduction Study (OLIVER) Study	Early Phase 1
Completed	`NCT03141008` - Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
Completed	`NCT03614039` - Effect of Probiotic and Smectite Gel on NAFLD	N/A
Recruiting	`NCT05125757` - Lifestyle Modification in Psoriatic Patients With Fatty Liver	N/A
Recruiting	`NCT05370053` - The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology	N/A
Recruiting	`NCT04371042` - PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
Completed	`NCT04004273` - Diabetes, Exercise and Liver Fat (DELIVER)	N/A
Completed	`NCT02520609` - Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
Recruiting	`NCT02265276` - A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease	Phase 3
Completed	`NCT02347007` - Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults	N/A
Completed	`NCT01934777` - Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis	Phase 3

NCT number	NCT05695118
Study type	Interventional
Source	Seoul National University Hospital
Contact
Status	Active, not recruiting
Phase	N/A
Start date	February 10, 2023
Completion date	December 31, 2024

Body Composition and Fatty Liver Disease

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms